Long-term therapy with Bevacizumab in a young patient affected by NF2. Stop or continue treatment? An update of a case report and review of the literature
We described the case of a young patient with NF2 treated for long time with Bevacizumab. Here, we report the update of the previous case report.
Source: Anti-Cancer Drugs - Category: Cancer & Oncology Tags: Case Reports Source Type: research
More News: Avastin | Brain | Cancer | Cancer & Oncology | Chemotherapy | Genetics | HER2 | History of Medicine | Neurofibromatosis | Neurology | Study